TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 10.94
+0.82 (8.10%)
Sep 30, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 4.46 billion as of October 1, 2026. Its market cap has decreased by -92.03% in one year.
Market Cap
4.46B
Enterprise Value
3.39B
Revenue
40.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.94
ChartMarket Cap Chart
Since June 23, 2025, HKG:2617's market cap has decreased from 9.33B to 4.46B, a decrease of -52.23%. That is a compound annual growth rate of -44.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.46B | -90.23% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TenNor Therapeutics (Suzhou) | 6.03B |
| Abbisko Cayman | 5.93B |
| CK Life Sciences Int'l., (Holdings) | 5.24B |
| Jacobio Pharmaceuticals Group | 4.75B |
| Ocumension Therapeutics | 4.15B |
| Shanghai Bao Pharmaceuticals | 4.01B |
| Hanx Biopharmaceuticals (Wuhan) | 3.95B |
| Qyuns Therapeutics | 3.79B |